Bladder Botox Injections
Botox Injections for the Detrusor Muscle
Botox injections for the detrusor muscle have become a popular treatment for women with overactive bladder (OAB) in recent years. OAB is characterized by symptoms such as urgency, frequency, and sometimes incontinence. Botox works by blocking the release of acetylcholine from the nervous system, which leads to a decrease in muscle contractions and a reduction in OAB symptoms.
Mechanism of action:
The detrusor muscle is the main muscle located in the walls of the bladder and its function is to perform the contractions that allow urine to be expelled from the bladder. Botox acts as a neurotoxic agent that disrupts the process of releasing acetylcholine at the synapses. As a result, there is a decrease in the force of contraction of the detrusor muscle, thus regulating the symptoms associated with OAB.
Treatment frequency:
Botox injections into the bladder have become a common and accepted treatment in cases where conventional treatments such as anticholinergic drugs are inadequate or cause intolerable side effects. In some countries, about 15-20% of patients with OAB receive Botox treatment.
Injection technique:
The injection is performed under cystoscopy with or without local anesthesia. During the procedure, several Botox injections are injected into the detrusor muscle (about 20 points), usually at a dose of 100 units. Recently, articles have been published examining the effectiveness of treatment with fewer injection points and similar effectiveness was found.
Treatment effectiveness:
Various studies indicate a high effectiveness of this treatment in reducing OAB symptoms. One study (Schurch et al., 2007) found that approximately 70% of patients treated with Botox reported significant improvement in symptoms, with a decrease in the amount of urgency and frequency of urination. Another study (Choi et al., 2014) demonstrated a 55% improvement in symptom reduction after Botox treatment, with a decrease in the frequency of urinary incontinence.
Complications:
Like any medical treatment, Botox injections have potential complications. Possible complications include infections, bleeding, weakness of the sphincter muscles, urinary tract infection, and urinary obstruction. Additional side effects may include pelvic pain or dysuria. Given the fact that Botox may find its way into the bloodstream (thereby paralyzing the entire body, including the respiratory muscles), the procedure should only be performed in a hospital with intensive care. Due to the risk of urinary retention (overactive bladder paralysis) following treatment, the treatment should only be performed in women who are able and willing to perform self-catheterization if required.
In conclusion, Botox injections into the detrusor muscle have been proven to be an effective and safe treatment for women with overactive bladder, especially in cases where conventional treatments do not provide a solution. However, it is important to be aware of the possible complications and to perform the treatment under appropriate medical supervision. In Israel, this treatment is still not included in the drug basket for this diagnosis.
